Category: Advances in MASH
Update on Treatment for Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis
G&H What is the likelihood that a patient with metabolic dysfunction-associated steatohepatitis has cirrhosis? WA The likelihood of cirrhosis depends on which patients with metabolic dysfunction-associated […]
Examining the Nomenclature Change From NAFLD and NASH to MASLD and MASH
G&H Why was the nomenclature for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis changed? MR From a historical perspective, the terms nonalcoholic fatty liver disease (NAFLD) […]